Which has grown faster, CNC or MRNA?

Over the past five years, CNC grew revenue faster — CNC at a 11.48% CAGR versus MRNA at -2.60%.

Which has been the better investment, CNC or MRNA?

Over the past 5-year, CNC delivered the higher annualized total return — CNC at 6.11% versus MRNA at -21.13%. Past performance doesn't predict future results.

Centene Corporation (CNC) vs Moderna, Inc. (MRNA)

CNC leads on 9 of 10 compared metrics.

A side-by-side comparison of Centene Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — CNC vs MRNA

growth of $100 · last 8y

CNC -10.5%MRNA +232.3%MRNA compounded faster

CNC MRNA

CNC vs MRNA: by the numbers

•CNC is the larger company ($29.94B vs $24.52B market cap).
•Both run net losses; CNC's is the smaller (-3.25% vs -143.55% net margin).
•CNC grew revenue faster over the past five years (11.48% vs -2.60% CAGR).

Which is better, CNC or MRNA?

Metric tally: CNC 9 · MRNA 1

It depends on what you're optimizing for:

GrowthCNC(faster 5Y revenue CAGR)

QualityCNC(higher ROIC)

Metrics side by side

Valuation

Metric	CNC	MRNA
Forward P/E	13.48	—
P/S ratio	0.15●	10.97
P/B ratio	1.40●	3.30
FCF yield	21.10%	—

Profitability

Metric	CNC	MRNA
Gross margin	14.93%●	-13.89%
Operating margin	-3.68%●	-153.35%
Net margin	-3.25%●	-143.55%
ROE	-30.07%●	-43.12%
ROIC	-13.41%●	-29.70%

Growth (annualized)

Metric	CNC	MRNA
Revenue CAGR (5Y)	11.48%●	-2.60%
EPS CAGR (5Y)	14.68%	—
FCF CAGR (5Y)	5.28%	126.92%●
Total return CAGR (5Y)	-3.98%●	-21.13%

Frequently asked

Which is better, CNC or MRNA?: It depends on your goal. growth: CNC (faster 5Y revenue CAGR); quality: CNC (higher ROIC). Across all compared metrics, CNC leads 9 to 1.
Which has grown faster, CNC or MRNA?: Over the past five years, CNC grew revenue faster — CNC at a 11.48% CAGR versus MRNA at -2.60%.
Which has been the better investment, CNC or MRNA?: Over the past 5-year, CNC delivered the higher annualized total return — CNC at 6.11% versus MRNA at -21.13%. Past performance doesn't predict future results.

Go deeper

Full CNC analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Centene P/E ratio Moderna P/E ratio Centene dividend yield Moderna dividend yield Centene ROE Moderna ROE Centene operating margin Moderna operating margin Centene revenue growth Moderna revenue growth Centene free cash flow Moderna free cash flow

Centene & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.